(“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for ...

People are encouraged to check those dates before throwing COVID-19 tests away. A Nasal Swab Test Could Predict the Severity ...

A study, published in the journal Neurology has explored whether healthy lifestyle choices, measured by a Brain Care Score ...

Related Behaviors and Risk of Common Age-Related Brain Diseases Across Severities of Genetic Risk," published in the November ...

It is no great secret that the auto insurance industry has faced considerable profitability concerns over the past few years, especially dating back to 2022.

The relationship between pneumonia and cardiovascular disease goes both ways: Pneumonia can increase the risk of heart ...

We rounded up the best shampoos that will treat eczema on your scalp with professional insights from four different ...

An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

For all three outcomes -- dementia, stroke, and late-life depression -- the median follow-up was 12.5 years. During follow-up ...